Details

Indication: Cancer

Clinical Stage: Phase II

Type of Compound: Small Molecule

Mechanism of Action: Inhibits XYZ protein

Patent Status: Patent granted

Contact Information

Email: contact@company.com

Phone: +123456789

Contact